Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mildronate for Acute Ischemic Stroke
NCT01800357Phase 2Unknown
- Sponsor
- Xijing Hospital
- Start
- Jan 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing mildronate with placebo (2 arms). Primary endpoint: Modified Rankin Scale at 3 months. Status: unknown.
02
Drugs
meldonium
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01800357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01800357.